BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $113,687,000 | +1.2% | 752,048 | -2.5% | 0.22% | +4.7% |
Q2 2022 | $112,368,000 | +7.3% | 771,172 | -12.7% | 0.21% | +35.3% |
Q1 2022 | $104,765,000 | -10.4% | 883,570 | +4.1% | 0.16% | +7.6% |
Q4 2021 | $116,984,000 | -18.5% | 848,879 | -17.8% | 0.14% | -31.6% |
Q3 2021 | $143,523,000 | +42.0% | 1,033,202 | -0.8% | 0.21% | +39.5% |
Q2 2021 | $101,097,000 | +49.5% | 1,041,365 | +5.2% | 0.15% | +31.0% |
Q1 2021 | $67,644,000 | -11.2% | 989,688 | +11.4% | 0.12% | -14.1% |
Q4 2020 | $76,135,000 | +36.3% | 888,284 | +3.4% | 0.14% | +17.4% |
Q3 2020 | $55,868,000 | -9.9% | 859,393 | +1.3% | 0.12% | -20.1% |
Q2 2020 | $61,999,000 | +133.4% | 848,019 | +8.7% | 0.14% | +77.8% |
Q1 2020 | $26,559,000 | -31.1% | 780,441 | +10.3% | 0.08% | -17.3% |
Q4 2019 | $38,527,000 | -15.3% | 707,684 | -35.1% | 0.10% | -23.4% |
Q3 2019 | $45,475,000 | +3.0% | 1,089,992 | +8.1% | 0.13% | +1.6% |
Q2 2019 | $44,144,000 | +36.7% | 1,008,046 | +60.7% | 0.13% | +37.0% |
Q1 2019 | $32,285,000 | +92.6% | 627,282 | +38.3% | 0.09% | +64.3% |
Q4 2018 | $16,766,000 | – | 453,409 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |